Purchase Order 75F40124P00192
Award Date
5/29/24
Potential Completion Date
6/29/25
Potential Value
$57K
Federal Agency
Food and Drug Administration
Awardee
Biomerieux Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a firm-fixed-price purchase order contract to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, for the delivery of the MYLA VIRTUAL MACHINE. The contract has a potential value of $245,075.57 and a completion date of April 13, 2024. This award is not associated with a set-aside program. Biomerieux Inc. is a worldwide leader in in vitro diagnostics,...
This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of its specialized clinical diagnostic equipment, reagents, and supplies. The $4,243.20 firm-fixed-price contract, awarded by the Food and Drug Administration (FDA), is a delivery order under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle. The contract has an ultimate completion date of September 23, 2024 and does not involve any set-aside designation....
This firm-fixed-price delivery order was awarded by a U.S. government agency to Biomerieux Inc., a global leader in in vitro diagnostics, for the purchase of its proprietary BioMerieux products. The $56,200 contract is for BioMerieux's specialized clinical diagnostic equipment, reagents, and supplies, including automated microbial identification systems, antibiotic susceptibility testing platforms, and molecular diagnostic technologies. The award was made under Biomerieux's Federal Supply...
The U.S. Food and Drug Administration (FDA) awarded a $9,659.86 firm-fixed-price delivery order contract to Biomerieux Inc., a global leader in in vitro diagnostics and microbiology testing solutions. The contract, which is not set-aside, provides the FDA with various Biomerieux diagnostic products and consumables, including API 20 E strips, API Listeria, VIDAS Salmonella, VIDAS Listeria, VITEK 2 GN, and VITEK 2 GP. This contract is part of a larger Indefinite Delivery Vehicle (IDV) that...
The U.S. federal agency Office of Administrative Services Procurement Management Branch awarded a firm-fixed-price Purchase Order to Biomerieux Inc., a global leader in in vitro diagnostics, for the purchase of MasterClave equipment for the Midwestern Lab. The contract, valued at $148,421.76, has a completion date of September 5, 2025. Biomerieux Inc. is a foreign-owned, for-profit manufacturer providing specialized diagnostic platforms and consumables to support infectious disease testing and...
This $212,471.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of Biomerieux's proprietary microbiology analyzer equipment, reagents, and technical support services to enable infectious disease testing and identification. This award is associated with Biomerieux's existing indefinite delivery contracts and blanket purchase agreements...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs' Veterans Health Administration to Biomerieux Inc., a foreign-owned for-profit manufacturer of medical diagnostic goods. The $101,585.60 contract is for clinical microbial identification and susceptibility testing services to support the VA's infectious disease testing needs. Biomerieux Inc. provides a range of proprietary microbiology and molecular biology diagnostic platforms, reagents, and...
This is a sole source purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Biomerieux Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic products. The $123,222.49 firm-fixed-price contract is for the provision of Biomerieux's proprietary microbiology and molecular biology testing platforms, reagents, and support services. This contract supports the VA's infectious disease testing and diagnostic requirements. Biomerieux has multiple...
This is a $235,020.16 firm fixed price purchase order awarded by the Defense Health Agency to Biomerieux Inc., a foreign-owned, for-profit manufacturer of diagnostic goods. The contract is for pathogenic bacteria cost per reportable, with a completion date of June 30, 2023. The original solicitation requested responses in the prescribed SF1449 format, with pricing on the provided contract line items. Biomerieux Inc. is a leading global provider of in vitro diagnostic solutions, including...
The U.S. Defense Health Agency (DHA) awarded a $164,607.03 firm-fixed-price purchase order contract to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic products and equipment. The contract is for the provision of reagents and supplies, with a completion date of September 30, 2023. Biomerieux Inc. is a leader in microbiology testing solutions for medical and industrial applications, providing products and services that support infectious disease testing and food...